World's Best Scientists 2026 revealed!
Cancer Letters
H-index 61

Cancer Letters

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 256 312 357 48

Additional Metrics

Number of Best Scientists*: 915
Documents by Best Scientists*: 887
Top 100 Ranked Scientists*: 24
SCIMAGO H-index: 230
SCIMAGO SJR: 2.756
Impact Factor: 10.1

Overview

Top Research Topics at Cancer Letters?

Cancer Letters facilitates discussions on Cancer research, Internal medicine, Molecular biology, Endocrinology and Cancer. While Cancer Letters focused on Cancer research, it was also able to explore topics like Cell growth, Cancer cell, Apoptosis, Carcinogenesis and Metastasis. It links adjacent topics like Cell growth with Cell cycle.

Discussions in the journal are anchored in the subject of Apoptosis and the similar topic of Cell biology. The studies on Internal medicine discussed can also contribute to research in the domains of Gastroenterology, Oncology and Carcinogen. The concepts on Molecular biology presented in Cancer Letters can also apply to other research fields, including Cell culture and Gene expression, In vitro, Gene, Biochemistry.

The work tackled in Cancer Letters goes beyond the discipline of Cell culture as it also encompasses Cell. The tackled Biochemistry research is interrelated with Pharmacology which concerns subjects like In vivo. Issues in Cancer were discussed, taking into consideration concepts from other disciplines like Immunology and Pathology.

  • Cancer research (37.44%)
  • Internal medicine (21.56%)
  • Molecular biology (17.61%)

What are the most cited papers published in the journal?

  • Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. (1546 citations)
  • Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles (1126 citations)
  • The insulin-like growth factor system and cancer. (977 citations)

Research areas of the most cited articles at Cancer Letters:

The main points discussed in the journal papers deal with Cancer research, Cancer, Internal medicine, Biochemistry and Molecular biology. While the journal papers focused on Cancer research, they were also able to explore topics like Cell growth, Carcinogenesis, Cancer cell, Apoptosis and Metastasis. In addition to Cancer research, the most cited articles aim to explore topics under Immunology and Pathology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Gene

The previous edition focused in particular on these issues:

The objective of Cancer Letters is to combine knowledge in the areas of Cancer research, Cancer, Cell migration, Metastasis and In vivo. Topics in Cancer research explored in Cancer Letters were investigated in conjunction with research in Cancer stem cell, Messenger RNA, Estrogen receptor, Long non-coding RNA and Sunitinib. Cancer cell is a primary topic of Cancer research in it.

Topics in Cancer cell were tackled in line with various other fields like Apoptosis, Cell cycle, AGR2 and MAPK/ERK pathway, p38 mitogen-activated protein kinases. The work on In vivo tackled in Cancer Letters brings together disciplines like In vitro, Gene knockdown, CXCL13, Survival rate and CXCR5. The study of Cell and how it intertwines with concepts under Carcinogenesis were explored in the presented Cell biology research.

The most cited articles from the last journal are:

  • Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies. (0 citations)
  • 125I seeds inhibit proliferation and promote apoptosis in cholangiocarcinoma cells by regulating the AGR2-mediated p38 MAPK pathway. (0 citations)
  • TEC kinase stabilizes PLK4 to promote liver cancer metastasis. (0 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Letters (based on the number of publications) are:

  • Hoyoku Nishino (73 papers) absent at the last edition,
  • Harukuni Tokuda (65 papers) absent at the last edition,
  • Masao Hirose (61 papers) absent at the last edition,
  • Takashi Sugimura (38 papers) absent at the last edition,
  • Yoichi Konishi (36 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Letters (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (235 papers) absent at the last edition,
  • National Institutes of Health (225 papers) absent at the last edition,
  • Shanghai Jiao Tong University (222 papers) absent at the last edition,
  • Peking Union Medical College (209 papers) absent at the last edition,
  • German Cancer Research Center (200 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2022 edition, 0.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 0.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 0.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 57.14% of all publications and 42.86% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Further Statistical Analysis on Cancer Letters

Cancer Letters is not only rich in profound and insightful medical research, but also significantly contributes to the overarching understanding and treatment of various types of cancers. The journal's impact on the research community can be better appreciated through an analysis of its article citation count, repeated author contribution, and geographical location of contributing institutions.

Additionally, its influence extends beyond the scientific community, having also impacted the fields of nursing and medical practice. For instance, Cancer Letters statistics and cited research often provide educational materials for nursing students, particularly those enrolled in advanced degree programs, such as np programs in maine. These programs utilize such resources to improve their curriculum, develop more effective teaching methodologies, and ultimately better prepare their students for their subsequent careers.

Top Publications

  • Clinical practice guidelines for the management of adult diffuse gliomas.

    (2020)
    424 Citations
  • Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?

    Sepideh Mirzaei;Ali Zarrabi;Farid Hashemi;Amirhossein Zabolian

    (2021)
    187 Citations
  • Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence.

    (2023)
    176 Citations
  • CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.

    Qiong Chen;Tao Liu;Yi Bao;Tangliang Zhao

    (2020)
    171 Citations
  • ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.

    Junru Chen;Chaofeng Ding;Yunhao Chen;Wendi Hu

    (2021)
    140 Citations
  • Long non-coding RNAs in the doxorubicin resistance of cancer cells.

    Saeed Ashrafizaveh;Milad Ashrafizadeh;Ali Zarrabi;Kiavash Husmandi

    (2021)
    140 Citations
  • Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.

    (2022)
    130 Citations
  • Writers, readers and erasers of RNA modifications in cancer.

    Rosaura Esteve-Puig;Alberto Bueno-Costa;Manel Esteller

    (2020)
    128 Citations
  • Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.

    N.E. Donlon;R. Power;C. Hayes;J.V. Reynolds

    (2021)
    114 Citations
  • Non-coding RNA in bladder cancer

    Yi Li;Gang Li;Xiangyang Guo;Haochen Yao

    (2020)
    103 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can open up diverse and flexible career options. Nursing remains one of the most popular and accessible healthcare paths, especially with the availability of online nursing programs that offer affordability and convenience for students juggling other commitments.

Advanced practice roles, such as Nurse Practitioners, require specialized education. Prospective students can find some of the cheapest online NP programs that combine quality training with manageable costs, accelerating entry into these in-demand professions.

For registered nurses aiming to enhance their credentials, RN to BSN programs offer a practical route to obtaining a Bachelor of Science in Nursing. These programs often provide flexible scheduling and online coursework designed to fit working professionals’ lives.

Further specialization is possible through doctoral education, such as cheapest DNP programs online that prepare nurses for leadership, clinical expertise, and academic roles. These programs are critical for advancing healthcare quality and innovation.

Best Scientists Contributing to This Journal